跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SGLT-2 inhibitors (type 2 diabetes)
首页
药物
SGLT-2 inhibitors (type 2 diabetes)
SGLT-2 inhibitors (type 2 diabetes)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
申请人: BOEHRINGER INGELHEIM INT
优先权: 2013
CN
EP
US
WO
18 件公开
THERAPEUTIC USES OF EMPAGLIFLOZIN
申请人: BOEHRINGER INGELHEIM INT
优先权: 2013
CN
EP
US
WO
8 件公开
THERAPEUTIC USES OF EMPAGLIFLOZIN
申请人: BOEHRINGER INGELHEIM INT
优先权: 2013
CN
EP
US
WO
8 件公开
METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELATED DISEASES USING SGLT-2 INHIBITORS
申请人: MERCK SHARP & DOHME
优先权: 2016
EP
US
WO
6 件公开
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
申请人: BROEDL ULI CHRISTIAN
优先权: 2014
US
5 件公开
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
申请人: BROEDL ULI CHRISTIAN
优先权: 2014
US
3 件公开
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
申请人: MERCK SHARP & DOHME
优先权: 2015
US
3 件公开
Halogenophenylthiazole carboxylic acid amide compounds containing phenylamidine structures as well as preparation method and application thereof
申请人: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2015
CN
Alkoxyphenylthiazole carboxylic acid amide compounds containing phenylamidine structures and application
申请人: FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2015
CN
Cyano-substituted double-target inhibitors containing methoxybenzene thiophene amide and application thereof
申请人: FOSHAN SAIWEISI MEDICINE SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
第 1 / 2 页
上一页
下一页
药物
反馈